Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
The Japanese yen strengthened sharply after Tokyo issued firm warnings that intervention to support the currency might be imminent. Dollar/yen fell to 156.72, down more than 2% on the day, sparking debate among strategists about whether verbal signals alone or active intervention - possibly combined with short-covering and low liquidity - drove the…
Anastasios Arima, the Chief Executive Officer of IPERIONX Ltd (NASDAQ: IPX, ASX: IPX), has made a significant direct investment in his company. On April 28, 2026, Mr. Arima purchased 110,000 ordinary shares at an average price of $4.4875 per share. This transaction represents a total capital outlay of approximately $493,625.The purchase occurs duri…
Vistance Networks said it has signed a definitive agreement to divest its RUCKUS Networks unit to Belden Inc. for $1.846 billion in cash. The announcement sent Vistance shares sharply higher and follows a string of asset dispositions that have left the company with substantial cash to return to investors. The transaction is slated to close in the s…
UBS has reduced its silver price projections across several horizons, citing weaker investment demand, softer industrial consumption particularly from photovoltaics, stronger mine output and falling ETF holdings. The bank trimmed its June, September, December and March 2027 targets and now expects a much smaller 2026 market deficit than previously …
The Bank of England's Monetary Policy Committee voted 8-1 to keep Bank Rate unchanged at 3.75% at its April meeting, presenting three alternative scenarios for how higher energy prices could affect inflation and output. Policymakers differed on the likely persistence and second-round effects of the shock from the Middle East conflict, with one memb…
Aebi Schmidt Holding AG, a global leader in specialty vehicles, will release its first quarter 2026 financial results before market open on May 14, 2026. The company will also hold a webcast and live conference call for investors and analysts. Headquartered in Switzerland and listed on NASDAQ, Aebi Schmidt operates across Europe and North America, …
CCC Intelligent Solutions Holdings Inc. announced that CFO Brian Herb will depart in May 2026, with Rodney Christo stepping in as interim CFO. The company also reported strong Q1 2026 financial results, with 12% revenue growth and 21% adjusted EBITDA growth compared to Q1 2025, reinforcing its growth trajectory in the insurance technology sector.
Roadzen Inc. (Nasdaq: RDZN) announced a non-binding Letter of Intent with a leading U.S. commercial insurance carrier to secure $30 million in underwriting capacity for a new commercial auto insurance program, expected to scale to $50 million over three years. Backed by over $50 million in committed premium demand from its U.S. producer network, th…
Parker Hannifin Corporation reported strong fiscal 2026 third quarter results, with record sales of $5.5 billion, up 11% year-over-year. Adjusted net income and EPS rose 16% and 18% respectively, driven by solid organic sales growth, strong order rates, and improved segment operating margins. The company increased its full-year guidance, expecting …
Yuanbao Inc., a Nasdaq-listed technology-driven online insurance distributor in China, announced the filing of its annual report on Form 20-F for fiscal year 2025 with the U.S. Securities and Exchange Commission. The report includes audited consolidated financial statements and is accessible via the company's investor relations website. Yuanbao ser…
FTI Consulting announced first quarter 2026 financial results featuring a 9.5% increase in revenues to $983.3 million and a 9.2% increase in EPS to $1.90 compared to the prior year quarter. Despite higher revenues, net income declined due to increased costs, higher SG&A expenses, interest expense, and a higher tax rate. The company reaffirmed its f…
Palvella Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapies for rare skin diseases and vascular malformations, will report its Q1 2026 financial results on May 7, 2026. The company will hold a conference call to discuss the results and corporate update. Palvella's lead products are investigational therapi…
TG Therapeutics, a commercial-stage biotechnology company focusing on B-cell disease treatments, announced a conference call on May 6, 2026, to discuss first quarter financial results and provide a business update for the remainder of 2026. The company recently obtained FDA approval for BRIUMVI for treating relapsing multiple sclerosis and continue…
Helus Pharma announced that Interim CEO Eric So will participate in a panel on health innovation at the 29th Annual Milken Institute Global Conference. The company is developing novel serotonergic agonists (NSAs) for mental health conditions including major depressive disorder and generalized anxiety disorder, with some products in advanced clinica…
Saia, Inc. reported first quarter 2026 financial results with revenue rising 2.4% to $806.2 million, while diluted EPS remained flat at $1.86 compared to Q1 2025. Operating income decreased 4.8%, reflecting a slightly higher operating ratio and lower LTL tonnage per workday despite increased shipments. The company continues investing in its nationa…
Hubbell Incorporated reported robust first quarter 2026 financial results with 11% net sales growth (8.2% organic), 16% increase in adjusted EPS to $3.93, and improved operating margins. The company raised its full-year 2026 diluted EPS guidance, anticipating strong sales and profit growth driven by key segments such as Electrical Solutions and Uti…
Laureate Education, Inc. reported first quarter 2026 financial results with new enrollments up 9% and total enrollments up 6%, revenue increasing 15% on a reported basis (1% constant currency). Operating loss widened due to academic calendar timing and higher expenses related to campus expansion projects. The company completed $105 million in share…
DT Midstream reported strong financial results for Q1 2026 with net income of $130 million and Adjusted EBITDA of $308 million. The company declared a $0.88 per share dividend and approved investments in key pipeline expansion projects including the Vector Pipeline 2028 expansion and Millennium Pipeline R2R project. These developments position DT M…
Barinthus Biotherapeutics disclosed its Q1 2026 financials showing reduced net loss and solid cash position. The company is advancing a transformative merger with Clywedog Therapeutics to create a differentiated pipeline focused on metabolic and autoimmune diseases. Clinical development of their lead asset VTP-1000 in celiac disease is progressing …
Dragonfly Energy Holdings Corp. (Nasdaq: DFLI), a leader in lithium battery manufacturing and energy storage solutions, announced it will release its first quarter 2026 financial and operational results on May 14, 2026 after market close. The earnings release will be followed by a conference call and webcast for investors and interested parties.
SIGA Technologies, a commercial-stage pharmaceutical company specializing in treatments and prevention of infectious diseases, announced a webcast and conference call on May 7, 2026, to discuss its first-quarter 2026 financial results and provide a business update. CEO Diem Nguyen and CFO Daniel Luckshire will participate in the call, which will be…
BridgeBio Pharma, a biopharmaceutical company specializing in medicines for genetic conditions, announced it will report its Q1 2026 financial results and provide commercial updates after market close on May 7, 2026, followed by a conference call. The webcast will be accessible via the company's investor website.
Botswana's central bank lifted its benchmark interest rate from 3.5% to 5.5%, citing a global energy shock tied to the Iran war. Governor Lesego Moseki said the monetary policy committee expects inflation to breach the 3% to 6% target range in the second quarter and projected inflation to average 8.7% in 2026 and 5.6% in 2027.
Alterity Therapeutics reported significant progress for its lead drug candidate ATH434 in treating Multiple System Atrophy (MSA), including positive FDA Type C meeting feedback supporting Phase 3 trial design and presentation of Phase 2 data demonstrating consistent efficacy in slowing disease progression. The company appointed experienced leadersh…
Macquarie reports ANZ returned to mortgage growth in March after ceding market share over the prior six months. The rebound has been concentrated in investor lending, where ANZ is growing at an annualised pace above 10% and is pricing interest-only investor loans materially below major competitors. The bank has also raised term deposit rates ahead …
